- Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences
- Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
- Eiger BioPharmaceuticals to Host Conference Call for Third Quarter 2022 Financial Results and Business Update on Thursday, November 3
- Eiger BioPharmaceuticals to Present at the H.C. Wainwright Third Annual Hepatitis B Virus (HBV) Virtual Conference
- Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback
- Eiger BioPharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference
- Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application
- Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences
As of last trade,
Eiger BioPharmaceuticals Inc (EIGR:NMQ) traded at 4.39, 24.36% above the 52 week low of 3.53 set on Jan 24, 2022.
3.53Jan 24 202210.02Mar 23 2022
Markit short selling activity
|Market cap||192.60m USD|
|EPS (TTM)||-2.41 |
Data delayed at least 15 minutes, as of Nov 29 2022 19:08 GMT.